Skip to main content
SpringerLink
Log in

Natural chemokine antagonism and synergism

  • Chapter
Book cover Chemokine Biology — Basic Research and Clinical Application

Part of the book series: Progress in Inflammation Research ((PIR))

  • 557 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Struyf S, Proost P, Van Damme J (2003) Regulation of the immune response by the interaction of chemokines and proteases. Adv Immunol 81: 1–44

    CAS  PubMed  Google Scholar 

  2. Proost P, Struyf S, Couvreur M, Lenaerts JP, Conings R, Menten P, Verhaert P, Wuyts A, Van Damme J (1998) Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor. J Immunol 160: 4034–4041

    CAS  PubMed  Google Scholar 

  3. Proost P, De Meester I, Schols D, Struyf S, Lambeir AM, Wuyts A, Opdenakker G, De Clercq E, Scharpe S, van Damme J (1998) Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem 273: 7222–7227

    Article  CAS  PubMed  Google Scholar 

  4. Struyf S, De Meester I, Scharpe S, Lenaerts JP, Menten P, Wang JM, Proost P, Van Damme J (1998) Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur J Immunol 28: 1262–1271

    CAS  PubMed  Google Scholar 

  5. Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, Lenaerts JP, Detheux M, Parmentier M, De Meester I, Scharpe S et al (1999) CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol 162: 4903–4909

    CAS  PubMed  Google Scholar 

  6. Proost P, Struyf S, Schols D, Opdenakker G, Sozzani S, Allavena P, Mantovani A, Augustyns K, Bal G, Haemers A et al (1999) Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction. J Biol Chem 274: 3988–3993

    Article  CAS  PubMed  Google Scholar 

  7. McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM (2000) Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289: 1202–1206

    Article  CAS  PubMed  Google Scholar 

  8. Hensbergen PJ, van der Raaij-Helmer EM, Dijkman R, van der Schors RC, Werner-Felmayer G, Boorsma DM, Scheper RJ, Willemze R, Tensen CP (2001) Processing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity. Eur J Biochem 268: 4992–4999

    Article  CAS  PubMed  Google Scholar 

  9. Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G, Detheux M, Parmentier M, Durinx C, Lambeir AM et al (2001) Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98: 3554–3561

    Article  CAS  PubMed  Google Scholar 

  10. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM (2002) Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 100: 1160–1167

    CAS  PubMed  Google Scholar 

  11. Christopherson KW 2nd, Hangoc G, Broxmeyer HE (2002) Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alphamediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 169: 7000–7008

    CAS  PubMed  Google Scholar 

  12. Ludwig A, Schiemann F, Mentlein R, Lindner B, Brandt E (2002) Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. J Leukoc Biol 72: 183–191

    CAS  PubMed  Google Scholar 

  13. Moser B, Wolf M, Walz A, Loetscher P (2004) Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25: 75–84

    Article  CAS  PubMed  Google Scholar 

  14. Clark-Lewis I, Kim KS, Rajarathnam K, Gong JH, Dewald B, Moser B, Baggiolini M, Sykes BD (1995) Structure-activity relationships of chemokines. J Leukoc Biol 57: 703–711

    CAS  PubMed  Google Scholar 

  15. Loetscher P, Clark-Lewis I (2001) Agonistic and antagonistic activities of chemokines. J Leukoc Biol 69: 881–884

    CAS  PubMed  Google Scholar 

  16. Loetscher P, Pellegrino A, Gong JH, Mattioli II, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis II (2000) The ligands of CXC chemokine receptor 3, I-TAC, Mig and IP10, are natural antagonists for CCR3. J Biol Chem 10: 10

    Google Scholar 

  17. Blanpain C, Migeotte I, Lee B, Vakili J, Doranz BJ, Govaerts C, Vassart G, Doms RW, Parmentier M (1999) CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 94: 1899–1905

    CAS  PubMed  Google Scholar 

  18. Nibbs RJ, Salcedo TW, Campbell JD, Yao XT, Li Y, Nardelli B, Olsen HS, Morris TS, Proudfoot AE, Patel VP et al (2000) C-C chemokine receptor 3 antagonism by the betachemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap. J Immunol 164: 1488–1497

    CAS  PubMed  Google Scholar 

  19. Ogilvie P, Bardi G, Clark-Lewis I, Baggiolini M, Uguccioni M (2001) Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5. Blood 97: 1920–1924

    Article  CAS  PubMed  Google Scholar 

  20. Martinelli R, Sabroe I, LaRosa G, Williams TJ, Pease JE (2001) The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b. J Biol Chem 276: 42957–42964

    Article  CAS  PubMed  Google Scholar 

  21. Chou CC, Fine JS, Pugliese-Sivo C, Gonsiorek W, Davies L, Deno G, Petro M, Schwarz M, Zavodny PJ, Hipkin RW (2002) Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta. Br J Pharmacol 137: 663–675

    Article  CAS  PubMed  Google Scholar 

  22. Wan Y, Jakway JP, Qiu H, Shah H, GarlisiI CG, Tian F, Ting P, Hesk D, Egan RW, Billah MM et al (2002) Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPgammaS binding. Eur J Pharmacol 456: 1–10

    Article  CAS  PubMed  Google Scholar 

  23. Xanthou G, Duchesnes CE, Williams TJ, Pease JE (2003) CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11. Eur J Immunol 33: 2241–2250

    CAS  PubMed  Google Scholar 

  24. Ogilvie P, Paoletti S, Clark-Lewis I, Uguccioni M (2003) Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytes. Blood 102: 789–794

    Article  CAS  PubMed  Google Scholar 

  25. Petkovic V, Moghini C, Paoletti S, Uguccioni M, Gerber B (2004) I-TAC/CXCL11 is a natural antagonist for CCR5. J Leukoc Biol 76: 701–708

    Article  CAS  PubMed  Google Scholar 

  26. Petkovic V, Moghini C, Paoletti S, Uguccioni M, Gerber B (2004) Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role. J Biol Chem 279: 23357–23363

    Article  CAS  PubMed  Google Scholar 

  27. Parody TR, Stone MJ (2004) High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells. Cytokine 27: 38–46

    Article  CAS  PubMed  Google Scholar 

  28. Ogilvie P, Thelen S, Moepps B, Gierschik P, da Silva Campos AC, Baggiolini M, Thelen M (2004) Unusual chemokine receptor antagonism involving a mitogen-activated protein kinase pathway. J Immunol 172: 6715–6722

    CAS  PubMed  Google Scholar 

  29. Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I (1997) An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 186: 131–137

    Article  CAS  PubMed  Google Scholar 

  30. Sasaki M, Hasegawa H, Kohno M, Inoue A, Ito MR, Fujita S (2003) Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice. J Immunol 170: 588–596

    CAS  PubMed  Google Scholar 

  31. Fulkerson PC, Zimmermann N, Brandt EB, Muntel EE, Doepker MP, Kavanaugh JL, Mishra A, Witte DP, Zhang H, Farber JM et al (2004) Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9). Proc Natl Acad Sci USA 101: 1987–1992

    Article  CAS  PubMed  Google Scholar 

  32. Struyf S, Proost P, Lenaerts JP, Stoops G, Wuyts A, Van Damme J (2001) Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1. Blood 97: 2197–2204

    Article  CAS  PubMed  Google Scholar 

  33. Struyf S, Stoops G, Van Coillie E, Gouwy M, Schutyser E, Lenaerts JP, Fiten P, van Aelst I, Proost P, Opdenakker G et al (2001) Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants. Biochemistry 40: 11715–11722

    Article  CAS  PubMed  Google Scholar 

  34. Gouwy M, Struyf S, Mahieu F, Put W, Proost P, Van Damme J (2002) The unique property of the CC chemokine regakine-1 to synergize with other plasma-derived inflammatory mediators in neutrophil chemotaxis does not reside in its NH2-terminal structure. Mol Pharmacol 62: 173–180

    Article  CAS  PubMed  Google Scholar 

  35. Gouwy M, Struyf S, Catusse J, Proost P, Van Damme J (2004) Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration. J Leukoc Biol 76: 185–194

    Article  CAS  PubMed  Google Scholar 

  36. Reca R, Mastellos D, Majka M, Marquez L, Ratajczak J, Franchini S, Glodek A, Honczarenko M, Spruce LA, Janowska-Wieczorek A et al (2003) Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 101: 3784–3793

    Article  CAS  PubMed  Google Scholar 

  37. Krug A, Uppaluri R, Facchetti F, Dorner BG, Sheehan KC, Schreiber RD, Cella M, Colonna M (2002) IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J Immunol 169: 6079–6083

    CAS  PubMed  Google Scholar 

  38. Vanbervliet B, Bendriss-Vermare N, Massacrier C, Homey B, de Bouteiller O, Briere F, Trinchieri G, Caux C (2003) The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med 198: 823–830

    Article  CAS  PubMed  Google Scholar 

  39. Kohrgruber N, Groger M, Meraner P, Kriehuber E, Petzelbauer P, Brandt S, Stingl G, Rot A, Maurer D (2004) Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. J Immunol 173: 6592–6602

    CAS  PubMed  Google Scholar 

  40. Dudek AZ, Nesmelova I, Mayo K, Verfaillie CM, Pitchford S, Slungaard A (2003) Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis. Blood 101: 4687–4694

    Article  CAS  PubMed  Google Scholar 

  41. Nesmelova IV, Sham Y, Dudek AZ, van Eijk LI, Wu G, Slungaard A, Mortari F, Griffioen AW, Mayo KH (2004) Platelet factor 4 and interleukin-8 CXC-chemokine heterodimer formation modulates function at the quarternary structural level. J Biol Chem 280: 4948–4958

    Article  PubMed  Google Scholar 

  42. Lortat-Jacob H, Grosdidier A, Imberty A (2002) Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci USA 99: 1229–1234

    Article  CAS  PubMed  Google Scholar 

  43. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP, Cerami A, Ralph P (1993) Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J Immunol 150: 3448–3458

    CAS  PubMed  Google Scholar 

  44. Von Hundelshausen P, Koenen RR, Sack M, Mause SF, Adriaens W, Proudfoot AE, Hackeng TM, Weber C (2004) Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105: 924–930

    Google Scholar 

  45. Paoletti S, Petkovic V, Sebastiani S, Danelon MG, Uguccioni M, Gerber BO (2005) A rich chemokine environment strongly enhances leukocyte migration and activities. Blood 105: 3405–3412

    Article  CAS  PubMed  Google Scholar 

  46. Sebastiani S, Danelon MG, Gerber BO, Uguccioni M (2005) CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of the first beta-strand of chemokine. Eur J Immunol 35: 746–756

    Article  CAS  PubMed  Google Scholar 

  47. Rodriguez-Frade JM, Mellado M, Martinez AC (2001) Chemokine receptor dimerization: two are better than one. Trends Immunol 22: 612–617

    CAS  PubMed  Google Scholar 

  48. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28: 235–242

    Article  CAS  PubMed  Google Scholar 

  49. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18: 2714–2723

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Research in Biomedicine, CH-6500, Bellinzona, Switzerland

    Mariagrazia Uguccioni

  2. Division of Allergology, Dept. of Rheumatology & Clinical Immunology/Allergology, Inselspital, CH-3011, Bern, Switzerland

    Basil O. Gerber

Authors
  1. Mariagrazia Uguccioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Basil O. Gerber
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Cell Biology, University of Bern, Baltzerstrasse 4, 3012, Bern, Switzerland

    Bernhard Moser

  2. NitroMed, Inc., 12 Oak Park Drive, Bedford, MA, 01730, USA

    Gordon L. Letts

  3. Bone and Inflammation, Eli Lilly and Company Lilly Corporate Center, Indianapolis, IN, 46285, USA

    Kuldeep Neote

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Uguccioni, M., Gerber, B.O. (2006). Natural chemokine antagonism and synergism. In: Moser, B., Letts, G.L., Neote, K. (eds) Chemokine Biology — Basic Research and Clinical Application. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7423-3_8

Download citation

Publish with us

Policies and ethics

Search

Navigation